CLINICAL_TRIALS
trial_result
· 2024-01-23
Clinical Trial Update: A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria [Phase 2]
Summary
Phase 2 trial assessing AK002 for antihistamine-resistant chronic urticaria has completed with posted results in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allakos Inc. | Conditions: Chronic Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2024-01-23